welbournes

The Department of Health and Social Care (DHSC) has today (21/09/2022) granted the following list of price concessions: Drug Pack size Price concession Exemestane 25mg tablets 30 £17.70 Ezetimibe 10mg tablets 28 £2.60 Famotidine 20mg tablets 28 £19.40 Famotidine 40mg tablets 28 £32.95 Febuxostat 80mg tablets 28 £3.05 Finasteride 5mg tablets 28 £6.51 Flucloxacillin 500mg [...]

The post September 2022 Price Concessions 2nd Update appeared first on PSNC Website.

Class 2 Medicines Recall: Sandimmun Oral Solution (Novartis Pharmaceuticals UK) Drug alert number: EL(22)A/40 Date issued: 20 September 2022 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sandimmun Oral Solution PL 00101/0124 Batch Number Expiry Date Pack Size First Distributed ADP326002 November 2024 50ml 06/05/2022 Active Pharmaceutical [...]

The post MHRA Class 2 Medicines Recall: Sandimmun Oral Solution Novartis Pharmaceuticals UK appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (20/09/2022) granted the following initial list of price concessions: Drug Pack size Price concession Alendronic acid 70mg tablets 4 £11.45 Amisulpride 100mg tablets 60 £13.94 Amisulpride 200mg tablets 60 £28.57 Amisulpride 50mg tablets 60 £9.20 Amorolfine 5% medicated nail lacquer 5 £7.34 Amoxicillin 250mg/5ml oral [...]

The post September 2022 Price Concessions 1st Update appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Temazepam 10mg and 20mg tablets. MSN/2022/078 Tier 2 – medium impact Date of issue 15th September 2022 Temazepam 10mg and 20mg tablets are in limited supply until w/c 5th December 2022 Alternative benzodiazepines and non-benzodiazepine hypnotics remain available and will be [...]

The post Medicine Supply Notification: Temazepam 10mg and 20mg tablets appeared first on PSNC Website.

Class 4 Medicines Defect Information: Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) Drug alert number: EL (22)A/39 Date issued: 14 September 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Atorvastatin 4mg/ml Oral Suspension PL 00427/0256 Batch Number Expiry Date [...]

The post MHRA Class 4 Medicines Defect Information: Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) appeared first on PSNC Website.